Methofill Self-Dose Injector 17.5 mg (Methotrexate (Methotrexate Sodium) SOLUTION) 17.5 MG

Methotrexate (Methotrexate Sodium) is a medication used for various conditions, including certain types of cancer and autoimmune diseases. This self-dose injector solution is designed for subcutaneous administration.

Strength

17.5 MG

Manufacturer / TM Owner

ACCORD HEALTHCARE INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Methotrexate is commonly used in the treatment of certain cancers, such as leukemia and lymphoma. It is also prescribed for autoimmune diseases like rheumatoid arthritis and psoriasis. The medication works by interfering with the growth of certain cells in the body. People often ask, 'What is Methotrexate used for?' and the answer includes these broad therapeutic areas.

Side Effects

Common effects of Methotrexate may include nausea, fatigue, and mild skin reactions at the injection site. Some individuals might experience temporary hair loss or mouth sores. These effects can vary depending on the individual and the condition being treated.

Precautions & Warnings

Methotrexate should be handled with care, as it is a potent medication. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Keep the solution out of reach of children and store it as directed.

Avoid Interactions

Methotrexate may interact with certain medications, including nonsteroidal anti-inflammatory drugs (NSAIDs) and antibiotics. Alcohol consumption should be avoided while using this medication. Always inform your healthcare provider about all medications you are taking to avoid potential interactions.

Frequently Asked Questions

Methotrexate is used to treat certain types of cancer and autoimmune diseases like rheumatoid arthritis and psoriasis.

The Methofill Self-Dose Injector is designed for subcutaneous administration, typically injected under the skin.

Common side effects may include nausea, fatigue, and mild skin reactions at the injection site.

Methotrexate may interact with certain medications, so it is important to consult a healthcare provider before combining it with other drugs.

Methotrexate should be stored as directed, typically at room temperature and out of reach of children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.